- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Dienogest.
Displaying page 1 of 1.
EudraCT Number: 2010-018590-38 | Sponsor Protocol Number: 70421 | Start Date*: 2010-04-14 | |||||||||||
Sponsor Name:LUMC | |||||||||||||
Full Title: The thrombogenicity of the dienogest/estradiol valerate containing oral contraceptive (Qlaira) | |||||||||||||
Medical condition: We will investigate the thrombogenicity of two different oral contraceptives: dienogest/estradiol valerate (Qlaira) in comparison to levonorgestrel/ethinylestradiol (Microgynon-30) used by healthy ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006633-41 | Sponsor Protocol Number: 310723 | Start Date*: 2007-04-11 | |||||||||||
Sponsor Name:Bayer Schering Pharma AG | |||||||||||||
Full Title: Monocenter, open-label, randomized study to determine the ovulation inhibitory effect of the combined oral contraceptives SH T04769G (0.015 mg Ethinylestradiol and 1.5 mg Dienogest in a modified re... | |||||||||||||
Medical condition: The aim of this monocenter, open-label, randomized study is to determine the ovulation inhibitory effect of the COC SH T04769G (0.15 mg Ethinylestradiol and 1.5 mg Dienogest in a modified release f... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017169-53 | Sponsor Protocol Number: BAY86-5258/13788 | Start Date*: 2011-01-17 | |||||||||||
Sponsor Name:Bayer HelathCare AG | |||||||||||||
Full Title: Estudio multicéntrico, abierto, de un brazo de tratamiento para evaluar la seguridad y la eficacia de la administración oral diaria de 2 mg de Dienogest en el tratamiento de la endometriosis en ado... | |||||||||||||
Medical condition: Sospecha clínica o confirmada de endometriosis en mujeres adolescentes post-menarquia de 12 a menos de 18 años de edad (Clinically suspected or confirmed endometriosis in post menarche female adole... | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) FI (Completed) DE (Completed) AT (Completed) FR (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019865-26 | Sponsor Protocol Number: ES-CO2 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Estetra S.A. | |||||||||||||
Full Title: A randomised, open-label, multi-centre, dose-finding study to evaluate cycle control of 15 mg or 20 mg estetrol combined with either 150 μg levonorgestrel or 3 mg drospirenone, compared to a combin... | |||||||||||||
Medical condition: Only healthy premenopausal volunteers will participate in this clinical trial. Intended indication: contraception. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004340-32 | Sponsor Protocol Number: 308961 | Start Date*: 2006-04-20 |
Sponsor Name:Bayer Schering Pharma AG | ||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, 7 Cycle Duration (196 Days), Phase 3 Study of Oral Estradiol Valerate/Dienogest Tablets for the Treatment of Dysfunction... | ||
Medical condition: Treatment of prolonged, excessive or frequent bleeding in women without organic pathology who desire oral contraception. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Completed) SE (Completed) DE (Completed) FI (Completed) HU (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003831-39 | Sponsor Protocol Number: LPRI421-202 | Start Date*: 2017-03-31 | ||||||||||||||||
Sponsor Name:Exeltis France S.A. | ||||||||||||||||||
Full Title: Multicentre, phase II, open label randomised clinical trial to assess the bleeding profile, tolerability and safety associated with the use of three prolonged release formulations containing a comb... | ||||||||||||||||||
Medical condition: Oral contraception for females aged 18-35 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: LT (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001614-13 | Sponsor Protocol Number: 301886 | Start Date*: 2005-06-08 |
Sponsor Name:Schering AG | ||
Full Title: A single-center, open-label, controlled, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) as compared to a seq... | ||
Medical condition: Contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-001613-34 | Sponsor Protocol Number: 304004 | Start Date*: 2005-02-01 |
Sponsor Name:Schering AG | ||
Full Title: A multi-center, double-blind, double-dummy, controlled, randomized study to evaluate cycle control and safety of a four-phasic oral contraceptive containing estradiol valerate and dienogest (SH T00... | ||
Medical condition: Contraception | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-001876-12 | Sponsor Protocol Number: LPRI-424/301 | Start Date*: 2019-12-16 | ||||||||||||||||
Sponsor Name:Chemo Research S.L. | ||||||||||||||||||
Full Title: A multicentre, uncontrolled trial on the contraceptive efficacy, safety, tolerability and pharmacokinetics of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during 13 cycles | ||||||||||||||||||
Medical condition: Oral contraception for females aged 18-45 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DE (Completed) LT (Completed) PT (Not Authorised) ES (Completed) BG (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003226-42 | Sponsor Protocol Number: 91550 | Start Date*: 2008-12-10 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A multicenter, randomized, double-blind, active-controlled, parallel group, 2-arm study to investigate the effect of estradiol valerate/dienogest compared to Microgynon on hormone withdrawal associ... | |||||||||||||
Medical condition: Hormone withdrawal associated symptoms of headache and pelvic pain suffered by patients receiving LNG containing oral contraception. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) DE (Completed) ES (Completed) GB (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-002263-13 | Sponsor Protocol Number: 91548 | Start Date*: 2009-03-13 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Multi-center, double-blind, randomized study to investigate the impact of a sequential oral contraceptive containing estradiol valerate and dienogest (SH T00658ID) compared to a monophasic contrace... | |||||||||||||
Medical condition: Reduced libido in women with acquired female sexual dysfunction (FSD) associated with oral contraceptive use. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) DE (Completed) BE (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003830-26 | Sponsor Protocol Number: LPRI-421/201 | Start Date*: 2017-02-24 | |||||||||||
Sponsor Name:Exeltis France | |||||||||||||
Full Title: Single center, phase II, open label randomized clinical trial to evaluate the inhibition of ovulation of three prolonged release formulations containing a combination of Dienogest and Ethinyl Estra... | |||||||||||||
Medical condition: Women’s healthcare (contraception, inhibition of ovulation). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000041-12 | Sponsor Protocol Number: 49/11/EDG/TP2 | Start Date*: 2012-03-23 | |||||||||||
Sponsor Name:Zentiva k.s. Prague | |||||||||||||
Full Title: Characterisation of ovulation inhibition and effects on metabolic parameters and haemostatic system of multiple administrations of a fixed-dose combination product containing 0.02 mg ethinylestradi... | |||||||||||||
Medical condition: Investigation of ovulation inhibition, effects on metabolic parameters and haemostatic system for indication of contraception | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001877-97 | Sponsor Protocol Number: LPRI-424/302 | Start Date*: 2020-02-19 | ||||||||||||||||
Sponsor Name:Chemo Research S.L. | ||||||||||||||||||
Full Title: A multicentre, double-blind, double-dummy, randomised trial on the contraceptive efficacy, tolerability and safety of LPRI-424 (dienogest 2 mg / ethinyl estradiol 0.02 mg) during nine cycles in com... | ||||||||||||||||||
Medical condition: Oral contraception for females aged 18-45 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: ES (Completed) CZ (Completed) SK (Completed) HU (Completed) PT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005005-28 | Sponsor Protocol Number: ADENOFERT | Start Date*: 2022-11-08 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA | |||||||||||||
Full Title: Assisted reproductive technology (ART) and pregnancy outcomes in women with adenomyosis (internal endometriosis) according to stimulation protocol in relation to immunological and endometrial featu... | |||||||||||||
Medical condition: Women with transvaginal ultrasound (TV-US)-based diagnosis of adenomyosis and women without adenomyosis but with similar baseline reproductive risks | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002178-17 | Sponsor Protocol Number: LPRI-424/304 | Start Date*: 2021-09-27 | |||||||||||
Sponsor Name:Chemo Research S.L. | |||||||||||||
Full Title: A multicentre, phase III, double-blind, randomised clinical trial to assess the efficacy and safety of LPRI-424 (dienogest 2.00 mg / ethinyl estradiol 0.02 mg) in the treatment of polycystic ovary ... | |||||||||||||
Medical condition: Hirsutism related to Polycystic Ovarian Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: PL (Completed) ES (Completed) CZ (Completed) LT (Completed) SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004184-36 | Sponsor Protocol Number: UKER-AN-HS-01 | Start Date*: 2016-01-05 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: Prospective, randomised, double-blind, placebo-controlled, single centre phase IIa clinical trial to investigate the safety and tolerability as well as the impact of a substitution of sexual hormon... | |||||||||||||
Medical condition: Substitution of sexual hormones in adult females with anorexia nervosa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-005625-11 | Sponsor Protocol Number: DC00050/91781 | Start Date*: 2009-09-08 | |||||||||||
Sponsor Name:Bayer Healthcare AG | |||||||||||||
Full Title: A multi-center, double-blind, double-dummy, randomized, controlled, parallel-group study to assess efficacy and safety of SH T00658ID compared to SH D593B in the treatment of primary dysmenorrhea | |||||||||||||
Medical condition: Primary dysmenorrhea in women requesting oral contraception | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
